• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Logo
  • Home
  • Understanding KCNT1
  • Parents & Caregivers
    • Newly Diagnosed
    • Early-Onset KCNT1 Epilepsies
      • Medications for Early-Onset Epilepsies
    • Sleep-Related Hypermotor Epilepsy (SHE)
    • Symptoms & Treatments Overview
    • Treatment Approaches
    • Genetics 101
    • Life Expectancy & Long-Term Planning  
    • Financial & Caregiving Tools
    • Support & Resources
    • Sign Up for Our Parent Contact Form
    • Share Your KCNT1 Story
    • Find a Doctor
    • World Map (Census)
  • Professionals
    • Clinicians
    • Industry
    • Researchers
      • Biospecimens
      • KCNT1 Funding
      • Publications
  • Research & Clinical Trials
    • Parents & Caregivers
    • Clinical Trials
    • Clinical Trial Educational Resources
  • Support Us
    • Get Involved
    • Ways to Give
      • Shop our Store
      • Host a Fundraiser
  • About Us
    • Our Mission
    • Our Team
    • Our Advisors
    • Our Approach
    • Our Partners
    • Our Families
  • News & Events
    • FDA Patient Session
    • KCNT1 Remembering Day: October 21
    • News
    • Newsletter
    • KCNT1 in Orlando
    • Past Conferences
      • KCNT1 Anaheim Family Conf
      • Million Dollar Bike Ride
  • Contact
  • D♡nate

Biogen Announces KCNT1 ASO in development

Aug 1

Viet Nguyen, MD, Medical Director, Research & Development, Biogen, Session IV: Pipeline for Gene Based Therapies.

ASO Therapies Show Promise for KCNT1

Welcome Stanford GC Interns

Footer

fluid-image
Donate Today
  • Parents & Caregivers
  • Researchers & Professionals
  • About Us
  • Contact
  • Subscribe
Gold 2025 Candid Seal
GAA Member Badge
Citizen Health Proud Partner 2025 Website Badge

Privacy Policy

© 2023 KCNT1 Epilepsy Foundation | All Rights Reserved | Disclaimer

EIN 84-2748218

Copyright © 2026